Ra Medical Systems Stock

Ra Medical Systems EBIT

Delisted

The EBIT of Ra Medical Systems (RMED) as of Aug 22, 2026 is -22.79 M USD. In the previous year, EBIT was -29.27 M USD — a change of -22.13% (higher).

EBIT

-22.79 MUSD

YoY

-22.13%

Last updated:

In 2026, Ra Medical Systems's EBIT was -22.79 M USD, a -22.13% increase from the -29.27 M USD EBIT recorded in the previous year.

The Ra Medical Systems EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2019
-52.61 base
Jan 1, 2020
-35.40 base
Jan 1, 2021
-29.27 base
Jan 1, 2022
-22.79 base
Jan 1, 2023 (e)
-72.73 base
Jan 1, 2024 (e)
-3.30 base
Jan 1, 2025 (e)
4.12 base
Jan 1, 2026 (e)
-21.75 base
YEAREBIT (M USD)
2026 est -21.75
2025 est 4.12
2024 est -3.30
2023 est -72.73
2022 -22.79
2021 -29.27
2020 -35.40
2019 -52.61
2018 -31.16
2017 -17.76
2016 -4.20
Access this data via the Eulerpool API

Ra Medical Systems Revenue

Ra Medical Systems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
1.27 M USD
-52.61 M USD
-56.96 M USD
Jan 1, 2020
259,000.00 USD
-35.40 M USD
-36.05 M USD
Jan 1, 2021
22,000.00 USD
-29.27 M USD
-25.07 M USD
Jan 1, 2022
14,000.00 USD
-22.79 M USD
-26.87 M USD
Jan 1, 2023 (e)
1.97 M USD
-72.73 M USD
-667.82 M USD
Jan 1, 2024 (e)
8.81 M USD
-3.30 M USD
-17.24 M USD
Jan 1, 2025 (e)
21.29 M USD
4.12 M USD
16.13 M USD
Jan 1, 2026 (e)
2.06 B USD
-21.75 M USD
-1.44 B USD

Ra Medical Systems Margins

Ra Medical Systems stock margins

The Ra Medical Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Ra Medical Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Ra Medical Systems.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
-224.67 %
-4,132.52 %
-4,474.23 %
Jan 1, 2020
-738.61 %
-13,668.34 %
-13,916.99 %
Jan 1, 2021
-6,990.91 %
-133,027.28 %
-113,954.54 %
Jan 1, 2022
-1,050.00 %
-162,778.56 %
-191,892.85 %
Jan 1, 2023 (e)
-1,050.00 %
-3,693.55 %
-33,916.57 %
Jan 1, 2024 (e)
-1,050.00 %
-37.50 %
-195.59 %
Jan 1, 2025 (e)
-1,050.00 %
19.36 %
75.75 %
Jan 1, 2026 (e)
-1,050.00 %
-1.06 %
-69.93 %

Ra Medical Systems Stock analysis

What does Ra Medical Systems do? Ra Medical Systems Inc. is a California-based company specializing in the development and sale of medical devices for the treatment of vascular diseases. The company was founded in 2002 and is headquartered in Carlsbad. The company was founded by Dr. Dean Irwin and Dr. Melissa Burstein, both experts in laser therapy. The company initially focused on developing laser systems for the treatment of skin diseases. In 2016, the company changed its business strategy and shifted its focus to the development of medical devices for the treatment of vascular diseases. Since then, the company has become a leading provider of devices for the treatment of peripheral artery occlusive disease (PAOD) and other vascular diseases. The business model of Ra Medical Systems Inc. is based on selling high-tech medical devices and their corresponding accessories. The company sells its products directly to medical facilities and healthcare providers in the US and some international markets. The company also provides training, technical support, and service to ensure the safe and effective use of its products. Ra Medical Systems Inc. offers two main products: the DABRA™ System and the Pharos™ System. Both systems use pulsed laser therapy for the treatment of vascular diseases. The DABRA™ System is a laser system specifically designed for the treatment of peripheral artery occlusive disease (PAOD). It is the only FDA-approved system that offers atherectomy laser therapy. The system enables fast and safe treatment of blocked arteries and is less invasive than traditional surgical procedures. The DABRA™ System also has the potential to reduce the need for long-term medication and repeated procedures, which can lower treatment costs. The Pharos™ System is a laser system specifically designed for the treatment of skin diseases such as psoriasis, vitiligo, and atopic dermatitis. The system uses a high-energy dose to selectively destroy abnormal functioning tissue without affecting surrounding tissue. The Pharos™ System has the potential to improve the quality of life for patients with skin diseases and expand therapeutic options for this patient group. Ra Medical Systems Inc. also offers a complete accessory catalog for its products, including catheters and accessories for the DABRA™ System and handpieces and cooling devices for the Pharos™ System. In conclusion, Ra Medical Systems Inc. is a leading provider of medical devices for the treatment of vascular diseases and skin diseases. The company specializes in the development of high-tech laser systems that provide safe and effective procedures for patients and doctors. The DABRA™ System is a revolutionary laser system for the treatment of PAOD that has the potential to reduce the need for invasive surgical procedures and long-term medication. The Pharos™ System expands therapeutic options for patients with skin diseases and has the potential to improve the quality of life for this patient group. Ra Medical Systems is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Ra Medical Systems's EBIT

Ra Medical Systems's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Ra Medical Systems's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Ra Medical Systems's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Ra Medical Systems’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Ra Medical Systems stock

EBIT of Ra Medical Systems is -22.79 M USD in 2026.

EBIT of Ra Medical Systems changed from -29.27 M USD to -22.79 M USD, representing a -22.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Ra Medical Systems since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Ra Medical Systems historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Ra Medical Systems

All Key Metrics — Ra Medical Systems